EuKedos S.p.A. (BIT:EUK)
Italy · Delayed Price · Currency is EUR 0.6600
0.00 (0.00%)
May 5, 2026, 5:49 PM CET
EuKedos Revenue
In the year 2025, EuKedos had annual revenue of 52.91M EUR with 2.35% growth. EuKedos had revenue of 27.12M in the half year ending December 31, 2025, with 5.04% growth.
Revenue
52.91M
Revenue Growth
+2.35%
P/S Ratio
0.28
Revenue / Employee
86.31K
Employees
681
Market Cap
15.01M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.91M | 1.22M | 2.35% |
| Dec 31, 2024 | 51.69M | 2.24M | 4.53% |
| Dec 31, 2023 | 49.45M | 2.41M | 5.12% |
| Dec 31, 2022 | 47.04M | 1.86M | 4.12% |
| Dec 31, 2021 | 45.18M | -1.81M | -3.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.62B |
| Amplifon | 2.40B |
| DiaSorin | 1.20B |
| EL.En. | 590.85M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 134.95M |
| Talea Group | 132.17M |
| Farmacosmo | 59.23M |